ACT Advisors’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

ACT Advisors’s Portfolio MEDS Stock Details MEDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-708	Closed	-$3.41K	–	98
2026 Q1	$3.41K	Buy	+708	New	+$9.72K	﹤0.01%	76

ACT Advisors's MEDS Position: Q2 2026 in Review

ACT Advisors sold out of DataMeds AI, Inc. Common Stock (MEDS) in Q2 2026, closing a stake of 708 shares — an estimated $3.41K sold.

ACT Advisors first reported a position in MEDS in Q1 2026 and held it in 1 quarter. The position peaked at $3.41K in Q1 2026. 0 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.

ACT Advisors reported no remaining DataMeds AI, Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
ACT Advisors sold 708 DataMeds AI, Inc. Common Stock shares in Q2 2026, an estimated $3.41K.
ACT Advisors first reported a position in DataMeds AI, Inc. Common Stock in Q1 2026 and held it in 1 quarter.
ACT Advisors's DataMeds AI, Inc. Common Stock position peaked at $3.41K in Q1 2026.
0 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q2 2026.

Based on ACT Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.